TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07585968: Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

Sponsor: Medtronic Cardiac Ablation Solutions · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 260 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07585968 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07585968 Rescue Dossier →